In a different study relating to the use of viruses in tumor immunotherapy, Wang and colleagues used an NF-κB-activating gene expression adeno-associated virus system to express an artificial neoantigen on the surface of tumor cells. The gene discussed is NFKB1; the disease is neoplasm.